# Aternali_2019_Recent advances in understanding and managing phantom limb pain.

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

REVIEW
Recent advances in understanding and managing phantom limb

pain [version 1; peer review: 2 approved]

Andrea Aternali
Department of Psychology, York University, Toronto, Ontario, Canada

, Joel Katz

v1

First published:
https://doi.org/10.12688/f1000research.19355.1
)

 23 Jul 2019,  (F1000 Faculty Rev):1167 (

8

Latest published:
https://doi.org/10.12688/f1000research.19355.1
)

 23 Jul 2019,  (F1000 Faculty Rev):1167 (

8

Abstract
Post-amputation phantom limb pain (PLP) is highly prevalent and very
difficult to treat. The high-prevalence, high-pain intensity levels, and
decreased quality of life associated with PLP compel us to explore novel
avenues to prevent, manage, and reverse this chronic pain condition. This
narrative review focuses on recent advances in the treatment of PLP and
reviews evidence of mechanism-based treatments from randomized
controlled trials published over the past 5 years. We review recent evidence
for the efficacy of targeted muscle reinnervation, repetitive transcranial
magnetic stimulation, imaginal phantom limb exercises, mirror therapy,
virtual and augmented reality, and eye movement desensitization and
reprocessing therapy. The results indicate that not one of the above
treatments is consistently better than a control condition. The challenge
remains that there is little level 1 evidence of efficacy for PLP treatments
and most treatment trials are underpowered (small sample sizes). The lack
of efficacy likely speaks to the multiple mechanisms that contribute to PLP
both between and within individuals who have sustained an amputation.
Research approaches are called for to classify patients according to shared
factors and evaluate treatment efficacy within classes. Subgroup analyses
examining sex effects are recommended given the clear differences
between males and females in pain mechanisms and outcomes. Use of
novel data analytical approaches such as growth mixture modeling for
multivariate latent classes may help to identify sub-clusters of patients with
common outcome trajectories over time.

Keywords
phantom limb pain, cortical reorganization, referred pain, neuropathic pain,
central sensitization, assessment, treatment

Open Peer Review

Reviewer Status

version 1

published
23 Jul 2019

Invited Reviewers
2

1

F1000 Faculty Reviews are written by members of

the prestigious 

F1000 Faculty

. They are

commissioned and are peer reviewed before

publication to ensure that the final, published version

is comprehensive and accessible. The reviewers

who approved the final version are listed with their

names and affiliations.

1

2

Tamar R Makin

, University College London,

London, UK

Jack W Tsao

, University of Tennessee Health

Science Center, Memphis, USA

Any comments on the article can be found at the

end of the article.

Page 1 of 11

 
 
 
 
 
 
 
F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

Corresponding author:

 Joel Katz (

jkatz@yorku.ca

)

Author roles: Aternali A
Review & Editing

: Writing – Original Draft Preparation, Writing – Review & Editing; 

Katz J

: Writing – Original Draft Preparation, Writing –

Competing interests:

 No competing interests were disclosed.

Grant information:
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

 This work was supported by funding from JK’s Canada Research Chair in Health Psychology. 

Copyright:
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 © 2019 Aternali A and Katz J. This is an open access article distributed under the terms of the 

Creative Commons Attribution Licence

,

How to cite this article:
review: 2 approved]

 Aternali A and Katz J. 

Recent advances in understanding and managing phantom limb pain [version 1; peer

 F1000Research 2019,  (F1000 Faculty Rev):1167 (

8

https://doi.org/10.12688/f1000research.19355.1

)

First published:

 23 Jul 2019,  (F1000 Faculty Rev):1167 (

8

https://doi.org/10.12688/f1000research.19355.1

) 

Page 2 of 11

 
 
Effective treatment of phantom limb pain (PLP) is a central issue 
that  continues  to  confront  amputees  and  their  clinicians.  The 
majority  of  amputees  report  PLP  at  some  point  after  limb  ampu-
tation,  and  lifetime  prevalence  estimates  are  between  50  and 
80%1–3.  The  pain  is  typically  neuropathic  in  origin  and  referred 
to  the  missing  limb  with  qualities  of  sensation  such  as  throb-
bing,  “pins  and  needles”,  shooting,  stabbing,  and  burning.  PLP 
is  usually  reported  within  the  first  week  after  amputation  and 
generally  decreases  in  severity  and  frequency  over  time  in  most  
individuals4.  It  is  accompanied  by  a  variety  of  secondary  effects, 
including  depression,  impairments  in  everyday  activities,  and 
decreased  quality  of  life5.  Over  the  past  50  years,  research-
ers  have  explored  how  PLP  can  be  treated  via  medication,  sur-
gery,  therapy,  and  numerous  other  approaches.  More  than  25 
treatments  for  PLP  are  currently  available  yet  not  one  is  widely 
accepted  or  clearly  superior  to  others6,7. This  likely  speaks  to  the 
multiple mechanisms that contribute to PLP. Treatments typically 
target  a  single  proposed  mechanism,  yet  amputees  can  have  PLP 
that  arises  from  multiple  mechanisms.  Consequently,  not  one  
intervention has been found to be consistently effective.

This  article  presents  a  narrative  review  of  randomized  control-
led  trials  (RCTs)  evaluating  the  efficacy  of  PLP  interventions 
published  over  the  past  5  years.  In  the  following  sections,  we 
review  evidence  for  the  efficacy  of  targeted  muscle  reinnerva-
tion  (TMR),  repetitive  transcranial  magnetic  stimulation  (rTMS), 
imaginal  phantom  limb  exercises,  mirror  therapy  (MT),  virtual 
and  augmented  reality,  and  eye  movement  desensitization  and 
reprocessing  (EMDR)  therapy.  The  Cochrane  Collaboration’s 
tool8  is  used  to  assess  risk  of  bias  for  the  RCTs  included  in  this  
review.  Each  included  RCT  was  evaluated  according  to  seven 
criteria  assessing  selection,  performance,  detection,  attrition, 
reporting,  and  other  biases.  Table  1  lists  the  main  features 
of  the  included  articles  along  with  their  associated  global  
risk-of-bias  rating.  The  Supplementary  Tables  1  to  10  present 
the  detailed  risk-of-bias  assessments  for  each  included  trial 
for  interested  readers.  Figure  1  summarizes  the  risk-of-bias  
assessments across the seven criteria for each included RCT.

Targeted muscle reinnervation
Proposed  mechanisms  underlying  PLP  have  traditionally  been 
classified  according  to  the  level  of  the  nervous  system:  periph-
eral  or  central.  Peripheral  mechanisms  include  activation  of 
residual  limb  neuromas  by  mechanical  stimulation,  circulating 
catecholamines,  pro-inflammatory  immunological  factors,  and 
other  pronociceptive  neurochemicals.  TMR  is  a  relatively  recent 
technique  that  involves  surgically  re-routing  and  coapting  the  
distal aspect of a transected nerve to a motor nerve that innervates 
an  adjacent  muscle.  Over  time,  the  coapted  residual  nerve  and 
motor  nerve  fasten  together  and  the  new  combined  nerve  rein-
nervates  the  muscle9. The  mechanism  by  which TMR  is  believed 
to  reduce  PLP  is  not  entirely  clear,  yet  researchers  have  sug-
gested  restoration  of  physiological  continuity  and  function10,  
neuroma  prevention11,  and  upstream  effects  on  cortical  
reorganization9.  Recent  research  has  suggested  that,  though 
originally  proposed  to  facilitate  use  and  control  of  myoelec-
tric  prostheses,  TMR  may  also  be  an  effective  way  to  reduce  
PLP10–13.

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

A  recent  RCT  examined  the  efficacy  of  TMR  for  PLP  among 
28  unilateral  and  bilateral  upper  or  lower  limb  amputees 
with  chronic  PLP  (30  limbs  treated)9.  Time  since  amputation 
ranged  from  less  than  1  year  to  more  than  10  years.  TMR  was  
compared  to  standard  treatment  involving  excising  the  neuroma 
and  burying  the  remaining  nerve  into  neighboring  muscle. 
Worst,  best,  and  current  levels  of  phantom  and  residual  limb 
pain  in  the  past  24  hours  were  assessed  pre-operatively  and  
post-operatively  at  3-month  intervals  for  1  year.  Secondary 
outcomes,  including  pain  behaviour,  pain  intensity,  and  pain  
interference  assessments  of 
the  Patient-Reported  Outcomes 
Measurement  Information  System  (PROMIS),  were  also  com-
pleted  at  these  assessments.  One  year  after  surgery,  significant 
between-group  differences  were  not  found  in  worst  PLP  inten-
sity,  worst  residual  limb  pain  intensity,  or  the  three  PROMIS  
pain  scales9.  However,  an  analysis  using  all  available  data 
(regardless of whether the last assessment was at the 1-year time 
point)  showed  that  worst  PLP  change  scores  at  the  final  assess-
ment  were  significantly  greater  in  TMR  than  standard  treat-
ment,  indicating  greater  reduction  in  PLP  for  the  former  group9.  
Higher  baseline  pain  scores  for  the  intervention  group  may 
explain  this  significant  result.  Taken  together,  the  results  do  not 
support  the  efficacy  of  TMR  for  PLP.  Future  research  should 
compare  TMR  with  a  less  invasive  but  putatively  equally  
efficacious treatment such as non-invasive brain stimulation14.

Repetitive transcranial magnetic stimulation
Maladaptive  cortical  re-organization  is  one  of  the  central  neu-
ral  mechanisms  thought  to  underlie  PLP.  It  has  been  proposed 
that,  after  amputation,  cortical  areas  that  once  represented  the 
amputated  extremity  become  reoccupied  by  adjacent  zones 
in  the  primary  somatosensory  and  motor  cortex  correspond-
ing  to  other  body  parts6,15.  Imagined  movement  of  the  phantom  
extremity  is  accompanied  by  brain  activity  in  regions  corre-
sponding to not only the lost extremity but also the adjacent body 
part.  PLP  has  been  shown  to  be  more  intense  among  individu-
als  for  whom  a  greater  degree  of  maladaptive  cortical  remapping  
has  taken  place6.  rTMS  has  been  explored  for  its  potential  in  
preventing  maladaptive  sensorimotor  cortical  remapping  and 
in  reducing  PLP16.  Targeting  the  somatosensory  and  motor  cor-
tex  using  a  magnetic  pulse  emitted  by  the  rTMS  coil  has  been  
proposed  to  activate  descending  inhibitory  pathways  to  the  
thalamus,  thereby  modulating  subsequent  ascending  nociceptive  
signals and reducing PLP16.

rTMS  was  evaluated  in  an  RCT  of  54  unilateral  trauma-related 
lower  limb  amputees16.  The  mean  time  since  amputation  was 
7.8  years.  Participants  were  randomly  assigned  to  receive  active 
rTMS  or  sham  rTMS  for  20  minutes  five  times  per  week  over 
2  weeks.  The  control  condition  was  exposed  to  a  sham  coil  that 
did  not  emit  a  magnetic  pulse  or  induce  a  tactile  sensation  on 
the  scalp.  For  the  active  rTMS  group,  the  authors  targeted  the 
hand  area of  motor cortex contralateral to  the  amputated leg,  cit-
ing  evidence  of  efficacy  for  this  stimulation  site  in  past  studies  
regardless  of  anatomic  location  of  the  pain17,18.  PLP  was  evalu-
ated daily for 1 week before the start of treatment and 15 and 30 
days  after  the  last  treatment.  Levels  of  depression  and  anxiety 
were  also  measured  at  each  of  these  time  points.  Between-group  

Page 3 of 11

s
a
i
b
f
o
k
s
i
R

k
s
i
r
h
g
H

i

-
n
e
e
w
t
e
b

l

a
u
d
s
e
r

i

r
o
P
L
P

t
s
r
o
w

-
t
s
o
p
r
a
e
y

i

1
n
a
p
b
m

i
l

n

i

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

i

t
n
a
c
fi
n
g
s
o
N

i

e
n

i
l

e
s
a
B

s
h
t
n
o
m
3

s
h
t
n
o
m
6

s
h
t
n
o
m
9

2
1

o
t

e
n

i
l

e
s
a
b
m
o
r
f

i

n
a
p

l

y
e
v
i
t
a
r
e
p
o
-
t
s
o
p
s
h
t
n
o
m

b
m

i
l

l

i

a
u
d
s
e
r
d
n
a
P
L
P
r
o
f

t
s
r
o
w
S
R
N
n

i

e
g
n
a
h
C

k
s
i
r

w
o
L

-
n
e
e
w
t
e
b

i

t
n
a
c
fi
n
g
s
o
N

i

e
n

i
l

e
s
a
B

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

f
o

i
l

u
m

i
t
s

0
2

y
r
e
g
r
u
s

s
h
t
n
o
m
2
1

i

n
a
p

e
m

i
t

p
u
-
w
o

l
l

o
f

-
t
s
o
p
s
y
a
d
0
3

S
M
T
r

n

i

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

r
e
h
t
i
e

t
a

s
e
r
o
c
s
P
L
P

-
t
s
o
p
s
y
a
d
5
1

e
u
g
o
a
n
a

l

l

a
u
s
v

i

a

a
v

i

S
M
T
r

)
S
A
V
(

l

e
a
c
s

s
d
n
o
c
e
s

6

-
4
5
(

h
c
a
e

d
n
o
c
e
s

r
e
p
s
y
a
d
5

2

r
o
f

k
e
e
w

l

,
)
s
a
v
r
e
t
n

i

s
k
e
e
w

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

k
s
i
r
h
g
H

i

p
u
o
r
g

t
n
a
c
fi
n
g
S

i

i

,
e
t
a
r
P
L
P
n

i

s
e
c
n
e
r
e
f
f
i

d

r
e
h
t
o
b
d
n
a
,
n
o
i
t
a
r
u
d

h
t
n
o
m
-
2

t
a
Q
E
P
m
o
r
f

o
N

l

.
y
n
o
p
u
-
w
o

l
l

o
f

s
e
c
n
e
r
e
f
f
i

d

t
n
a
c
fi
n
g
s

i

i

k
s
i
r
h
g
H

i

h
t
n
o
m
-
2

t
a
r
e
h
t
o
b
d
n
a

n

i

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

,
y
t
i
s
n
e
t
n

i

,
e
t
a
r
S
L
P

l

.
y
n
o
p
u
-
w
o

l
l

o
f

d
e
t
r
o
p
e
r

s
n
o
s
i
r
a
p
m
o
c

p
u
o
r
g
-
n
e
e
w
t
e
b
o
N

e
m
o
c
t
u
o

i

n
a
m

r
o
f

e
r
u
s
a
e
m

t
n
a
c
fi
n
g
S

i

i

.
I

P
B
h
t
i

w

k
s
i
r
h
g
H

i

p
u
o
r
g

t
n
a
c
fi
n
g
S

i

i

P
L
P
S
A
V
n

i

e
c
n
e
r
e
f
f
i

d

,
s
e
r
o
c
s

I

D
B

,
y
t
i
r
e
v
e
s

V
d
n
a
,

H
M

,
F
S

,
F
P
d
n
a

6
3
-
F
S
e
h
t

f
o

l

s
e
a
c
s
b
u
s

p
u
-
w
o

l
l

o
f

l
l

a
t
a
p
u
o
r
g

T
M
e
h
t

f
o

r
u
o
v
a
f

n

i

s
e
m

i
t

e
n

i
l

e
s
a
B

h
t
n
o
m
1

s
h
t
n
o
m
2

e
n

i
l

e
s
a
B

s
k
e
e
w
4

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

S
A
V
a
v

i

e
r
i
a
n
n
o
i
t
s
e
u
Q
n
o
i
t
a
u
a
v
E

l

i

n
a
P

f
e
i
r

B
d
n
a

)

Q
E
P
(

)
I
P
B

(

y
r
o
t
n
e
v
n
I

m
o
t
p
m
y
s
b
m

i
l

m
o
t
n
a
h
P

.
2

i

Q
E
P
a
v
d
e
r
u
s
a
e
m

r
e
h
t
o
b

d
n
a

,
e
t
a
r

,
y
t
i
s
n
e
t
n

i

)
S
L
P
(

e
n

i
l

e
s
a
B

s
k
e
e
w
4

s
h
t
n
o
m
3

s
h
t
n
o
m
6

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

.
1

S
A
V
a
v

i

d
e
t
a
u
a
v
e

l

e
f
i
l

f
o

y
t
i
l

a
u
Q

.
  2

6
3
-
F
S
a
v

i

s
u
t
a
t
s

l

i

l

a
c
g
o
o
h
c
y
s
P

.
  3

I

i

D
B
g
n
s
u
d
e
r
u
s
a
e
m

i

s
s
e
h
t
s
o
r
P
a
v
d
e
r
u
s
a
e
m

i

r
e
h
t
o
b
d
n
a

,
n
o
i
t
a
r
u
d

4

r
o
f

k
e
e
w

r
e
p
s
e
m

i
t

s
k
e
e
w

s
e
t
u
n
m
5
1

i

r
e
p
s
y
a
d
5

4

r
o
f

k
e
e
w

s
k
e
e
w

s
e
t
u
n
m
5
1

i

y

l
i

a
d
T
M

r
o
f

e
m
o
h

f
o

t
a

p
u
o
r
g
E
  P

s
k
e
e
w
4

d
e
m
r
o
f
r
e
p

i

s
e
s
c
r
e
x
e

5
1

h
t
i

w
y

l
i

a
d

s
n
o
i
t
i
t
e
p
e
r

i

s
g
n
d
n
F

i

s
t
n
e
m
s
s
e
s
s
A

e
m
o
c
t
u
o
n
i
a
M

)
s
(
e
r
u
s
a
e
m

t
n
e
m
t
a
e
r
T

n
o
i
t
a
r
u
d

t
n
e
m
t
a
e
r
T

e
m

i
t
n
a
e
M

r
o
f

)
s
(
n
o
s
a
e
R

d
n
a
(
e
t
i

S

,
r
a
e
y
,
s
r
o
h
t
u
A

d
n
a
n
o
i
t
a
t
u
p
m
a

)
e
g
a
t
n
e
c
r
e
p

e
l
p
m
a
s
d
n
a

.

n
i
a
p
b
m

i
l

m
o
t
n
a
h
p
f
o
t
n
e
m
t
a
e
r
t

e
h
t
g
n
i
t
a
g
i
t
s
e
v
n

i

e
l
c
i
t
r
a

i

s
h
t
n

i

d
e
w
e

i

v
e
r

e
r
u
t
a
r
e
t
i
l

e
h
t

f
o
y
r
a
m
m
u
S

.
1

e
l
b
a
T

,
e
t
a
r

,
y
t
i
s
n
e
t
n

i

P
L
P

.
1

o
w

t

r
u
o
h

1
~

s
y
a
d
8
5
4

l

%
0
7
=
r
a
u
c
s
a
v
s
y
D

%
0
3
=
r
e
h
O

t

%
3
7
=
K
A

%
7
2
=
K
B

9
1
.
l
a
t
e

i
l
l

e
n
u
r
B

)
0
4
=
n
(

)
5
1
0
2
(

y
r
e
g
r
u
s

a
m
o
r
u
e
n

n
o
i
t
a
v
r
e
n
n
e
r

i

d
r
a
d
n
a
t
S

.
2

S
M
T
r

e
v
i
t
c
A

S
M
T
r

m
a
h
S

.
1

.
2

N
A
P
A
S

I

.
1

l

o
c
o
t
o
r
p

d
r
a
d
n
a
t
S

.
2

t
n
e
m
t
a
e
r
t

/

A
N

d
e
t
e
g
r
a
T

.
1

1

n
a
h
t

s
s
e
L
(

l

e
c
s
u
m

e
r
o
m
o
t

0
1

r
a
e
y

n
a
h

t

s
p
u
o
r
g

n
o
i
t
a
t
u
p
m
a

)
e
g
n
a
r
(

e
c
n
s

i

%
0
1
=
n
o

i
t

c
e

f

n

I

%
0
9
=
a
m
u
a
r
T

%
3
1
=
E
U

%
7
8
=
E
L

s
e
g
a
t
n
e
c
r
e
p

n
o
i
t
a
t
u
p
m
a

f
o

)
s
r
a
e
y

s
r
a
e
y

8
7

.

%
0
0
1
=
a
m
u
a
r
T

%
0
0
1
=
E
L

)
9
1
0
2
(

9
.
l
a
t
e

i

n
a
n
a
m
u
D

)
8
2
=
n
(

e
z
i
s

)
6
1
0
2
(

6
1
.
l
a
t
e

a
r
e
v
a
a
M

l

)
4
5
=
n
(

)
r
o
r
r
i

m
d
e
r
e
v
o
c
(

l

o
r
t
n
o
C

T
M

.
1

.
2

s
h
t
n
o
m
5
4

.

4
2
–
5
5
.
0
(

)
s
h
t
n
o
m

%
0
0
1
=
a
m
u
a
r
T

%
0
4
=
E
A

%
0
6
=
E
B

)
5
1
=
n
(

)
7
1
0
2
(

0
2
.
l
a
t
e
n
n
F

i

)
n
o
i
t
a
z

i
l

a
u
s
v

i

l

o
r
t
n
o
C

.
3

l

a
t
n
e
m

(

)
E
P
(

i

e
s
c
r
e
x
e

m
o
t
n
a
h
P

T
M

.
1

.
2

s
h
t
n
o
m

5
2
.

3
1

3
5
–
3
(

)
s
h
t
n
o
m

%
0
0
1
=
a
m
u
a
r
T

%
0
0
1
=
K
B

l

u
ğ
o
r
o
f
a
n
A

l

u
ğ
o
k
n
ü
ü
K

l

)
9
1
0
2
(

1
2
.
l
a
t
e

)
0
4
=
n
(

Page 4 of 11

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
s
a
i
b
f
o
k
s
i
R

k
s
i
r

h
g
H

i

-
n
e
e
w
t
e
b

k
s
i
r

h
g
H

i

d
e
t
r
o
p
e
r

s
n
o
s
i
r
a
p
m
o
c

p
u
o
r
g
-
n
e
e
w
t
e
b
o
N

e
m
o
c
t
u
o

i

n
a
m

r
o
f

s
e
r
u
s
a
e
m

n

i

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

r
e
h
t
i
e

t
a

s
e
r
o
c
s
P
L
P

e
m

i
t

p
u
-
w
o

l
l

o
f

k
s
i
r

h
g
H

i

-
n
e
e
w
t
e
b

i

t
n
a
c
fi
n
g
s
o
N

i

d
n
e
e
h
t

t
a
y
t
i
s
n
e
t
n

i

P
L
P

n

i

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

t
n
e
m
t
a
e
r
t

f
o

k
s
i
r

h
g
H

i

-
n
e
e
w
t
e
b

i

t
n
a
c
fi
n
g
s
o
N

i

h
t
n
o
m
-
6

t

A

.

p
u
-
w
o

l
l

o
f

e
r
e
w
e
r
e
h
t

,

p
u
-
w
o

l
l

o
f

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

k
e
e
w
-
0
1

r
o

-
4

t
a

-
n
e
e
w
t
e
b

t
n
a
c
fi
n
g
s

i

i

i

t
n
a
c
fi
n
g
s
o
N

i

e
n

i
l

e
s
a
B

s
k
e
e
w
5

s
h
t
n
o
m
3

f
o
d
n
e
r
e
t
f
a

t
n
e
m
t
a
e
r
t

e
n

i
l

e
s
a
B

s
k
e
e
w
4

s
k
e
e
w
8

s
k
e
e
w
2
1

s
k
e
e
w
6
1

l

)
y
n
o

l

o
r
t
n
o
c

,
s
k
e
e
w
0
2
(

e
n

i
l

e
s
a
B

s
y
a
d
4

e
n

i
l

e
s
a
B

s
k
e
e
w
4

s
k
e
e
w
0
1

s
h
t
n
o
m
6

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

y
b
d
e
w
o

l
l

o
f

T
M

f
o

r
o
v
a
f

n
o

s
e
c
n
e
r
e
f
f
i

d
p
u
o
r
g

n

i

l

,
y
n
o
n
o
i
t
a
r
u
d
P
L
P

.
T
M
d
e
r
e
v

i
l

e
d
-
f
l
e
s

s
k
e
e
w
6

y
b

d
e
r
e
v

i
l

e
d
-
f
l
e
s

y
b

d
e
r
e
v

i
l

e
d

t
n
e
m
t
a
e
r
t

-
f
l
e
s

f
o

r
o
t
o
m
o
s
n
e
S

.
3

b
m

i
l

t
c
a
t
n

i

e
h
t

d
e
r
e
v

i
l

e
d
-
f
l
e
s

y
b
d
e
w
o

l
l

o
f

o
t

i

s
e
s
c
r
e
x
e

i

s
e
s
c
r
e
x
e

T
M

)

i

R
D
M
E
(
g
n
s
s
e
s
s
o
p
e
r
d
n
a
n
o
i
t
a
z
i
t
i
s
n
e
s
e
d

t
n
e
m
e
v
o
m
e
y
e
d
n
a
,
y
t
i
l

a
e
r
d
e
t
n
e
m
g
u
a
,
)
T
M

(
y
p
a
r
e
h
t

r
o
r
r
i

m

,
)
S
M
T
r
(
n
o
i
t
a
u
m

l

i
t
s
c
i
t
e
n
g
a
m

l

i

a
n
a
r
c
s
n
a
r
t
e
v
i
t
i
t
e
p
e
r

e
m
o
c
t
u
o

i

n
a
m

r
o
f

s
h
t
n
o
m
4
2

i

n
a
p
d
n
a

l

e
a
c
s

s
s
e
r
t
s
d

i

s
e
r
u
s
a
e
m

l

e
a
c
s
g
n
i
t
a
r

1

r
e
v
o

h
t
n
o
m

k
s
i
r

h
g
H

i

d
e
t
r
o
p
e
r

s
n
o
s
i
r
a
p
m
o
c

p
u
o
r
g
-
n
e
e
w
t
e
b
o
N

e
n

i
l

e
s
a
B

h
t
n
o
m
1

f
o

s
t
i
n
u

e
v
i
t
c
e
b
u
s

j

e
h
t

a
v

i

i

s
n
o
s
s
e
s

e
r
a
c

e
n
i
t
u
o
R

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

r
u
o
h
-
e
n
o

2
1

R
D
M
E

.
1

.
2

)
s
h
t
n
o
m

8
3
–
2
(

i

,
n
o
i
t
a
v
r
e
n
n
e
r
e
c
s
u
m
d
e
t
e
g
r
a
t

l

i

g
n
s
u
s
n
o
i
t
n
e
v
r
e
t
n

i

m
o
r
f
s
t
l
u
s
e
R

%
5
4
=
s
e
e
b
a
D

t

i

%
0
5
=
a
m
u
a
r
T

%
5
=
r
e
c
n
a
C

%
0
4
=
K
A

%
0
6
=
K
B

j

i

d
a
e
n
m
a
t
s
o
R

)
7
1
0
2
(

6
2
.
l
a
t
e

)
0
6
=
n
(

j

r
o
a
m
d
n
a

,
t
n
e
m
s
s
e
s
s
a

f
o

s
e
m

i
t

,
s
e
r
u
s
a
e
m
e
m
o
c
t
u
o

i

n
a
m
s
a

l
l

e
w
s
a

n
o
i
t
a
r
u
d

d
n
a

s
p
u
o
r
g

t
n
e
m
t
a
e
r
T

.
n
w
o
h
s

e
r
a

n
o
i
t
a
t
u
p
m
a

e
c
n
s

i

e
m

i
t

n
a
e
m
d
n
a

,
n
o
s
a
e
r

,
e
t
i
s

e
h
t

,
y
d
u
t
s

h
c
a
e

r
o
F

.
e
v
o
b
a

d
e
z
i
r
a
m
m
u
s

e
r
a

y
p
a
r
e
h

t

l

.
y
e
v
i
t
c
e
p
s
e
r

,
s
n
o
i
t
a
t
u
p
m
a

y
t
i

m
e
r
t
x
e

r
e
w
o

l

d
n
a

r
e
p
p
u

o
t

r
e
f
e
r

E
L

d
n
a

E
U

.
8
l
o
o
t

’

s
n
o
i
t
a
r
o
b
a

l
l

o
C
e
n
a
r
h
c
o
C
e
h
t

y
b

d
e
s
s
e
s
s
a

s
a

g
n
i
t
a
r

i

s
a
b
-
f
o
-
k
s
i
r

l

a
b
o
g

l

l

’

s
e
c
i
t
r
a

e
h
t

s
e
b
i
r
c
s
e
d

n
m
u
o
c

l

l

a
n
fi

e
h
T

.

d
e
d
u
c
n

l

i

e
r
a

s
g
n
d
n
fi

i

g
n
i
t
a
r

0
1
–
0

c
i
r
e
m
u
n

e
h
t

o
t

s
r
e
f
e
r

S
R
N

.
r
o
h
t
u
a

e
h
t

y
b

d
e
t
r
o
p
e
r

t
o
n

s
a
w

t
a
h
t

n
o
i
t
a
m
r
o
f
n

i

s
e
t
o
n
e
d

R
N

.
t
n
o

i

j

)
E
(

w
o
b
e

l

d
n
a

)

K

(

e
e
n
k

e
h
t

)

B

(

w
o
e
b

l

d
n
a

)

A

(

e
v
o
b
a

d
e
m
r
o
f
r
e
p

s
n
o
i
t
a
t
u
p
m
a

o
t

r
e

f
e
r

E
B

d
n
a

,

E
A

,

K
B

,

K
A

’

s
e
e
t
u
p
m
A

n

i

m
o
t
n
a
h
P

r
o
f

n
o
i
t
n
e
v
r
e
t
n
I

n
o
i
t
a
v
e

i

l
l

A

i

a
c
u
L

a
t
n
a
S

,

N
A
P
A
S

I

i

;
n
a
p

b
m

i
l

m
o
t
n
a
h
p

,

P
L
P

;

i

g
n
n
o
i
t
c
n
u
f

l

i

a
c
s
y
h
p

,
F
P

l

;
e
b
a
c

i
l

p
p
a

t
o
n

,

/

A
N

;
h
t
l
a
e
h

l

a
t
n
e
m

,

H
M

;
y
r
o
t
n
e
v
n
I

i

n
o
s
s
e
r
p
e
D

k
c
e
B

,
I

D
B

l

.
e
a
c
s

.
y
t
i
l

a
t
i
v

,

V

;
y
e
v
r
u
S
m
r
o
F
t
r
o
h
S
m
e
t
I
-
6
3
,
6
3
-
F
S

;

i

g
n
n
o
i
t
c
n
u
f

l

i

a
c
o
s

,
F
S

;
n
o
i
t
a
t
i
l
i

b
a
h
e
r
o
r
u
e
N

Page 5 of 11

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

s
e
t
u
n
m
0
2

i

l

i

a
s
r
e
v
n
U
d
n
a
S
A
V
a
v

i

)
S
P
U

(

e
r
o
c
S
n
a
P

i

y
a
d
y
r
e
v
e

s
y
a
d
4

r
o
f

l

l

a
r
e
t
a
a
r
t
n
o
C

T
M

.
1

.
2

s
u
o
e
n
a
t
u
c
s
n
a
r
t

e
v
r
e
n

l

a
c
i
r
t
c
e
e

l

n
o
i
t
a
u
m

l

i
t
s

s
y
a
d
5
4

R
N

%
6
2
=
E
U

%
4
7
=
E
L

)
6
2
=
n
(

)
6
1
0
2
(

4
2
.
l
a
t
e
k
a

l
i

T

,
n
o
i
t
a
r
u
d

,
y
c
n
e
u
q
e
r
f

d
e
r
u
s
a
e
m

(

y
t
i
s
n
e
t
n

i

P
L
P

d
n
a

0
1

t
s
a
e

l

t

A

i

e
t
u
n
m
-
0
3

)
S
R
N
a
v

i

i

s
n
o
s
s
e
s

s
k
e
e
w
4

d
e
w
o

l
l

o
f

s
s
o
r
c
a

t
n
e
m
t
a
e
r
t
e
e
t

l

y
b

d
e
w
o

l
l

o
f

T
M

.
2

d
e
t
n
e
m
g
u
a

y
t
i
l

a
e
r

g
n
s
u

i

d
e
w
o

l
l

o
f

T
M

.
1

s
h
t
n
o
m
5
3
~

l

%
0
4
=
r
a
u
c
s
a
v
s
y
D

%
2
3
=
a
m
u
a
r
T

%
4
1
=
r
o
m
u
T

%
4
1
=
r
e
h
O

t

%
1
6
=
K
A

%
7
=
K

%
2
3
=
K
B

)
8
1
0
2
(

5
2
.
l
a

t

e

l

e
g
n
a
g
h
t
o
R

)
5
7
=
n
(

i

s
g
n
d
n
F

i

s
t
n
e
m
s
s
e
s
s
A

e
m
o
c
t
u
o
n
i
a
M

)
s
(
e
r
u
s
a
e
m

t
n
e
m
t
a
e
r
T

n
o
i
t
a
r
u
d

s
p
u
o
r
g

t
n
e
m
t
a
e
r
T

e
m

i
t
n
a
e
M

r
o
f

)
s
(
n
o
s
a
e
R

d
n
a
(

e
t
i

S

,
r
a
e
y
,
s
r
o
h
t
u
A

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

S
A
V
a
v

i

r
o
f

i

t
h
g
n
d
n
a

d
n
a

r
o
r
r
i

m

(

s
k
e
e
w
4

)
y
p
a
r
e
h
t

e

l
i
t
c
a
t

s
e
t
u
n
m
5

i

i

g
n
n
r
o
m

y
r
e
v
e

n
o
i
t
a
n
b
m
o
C

i

e

l
i
t
c
a
T

T
M

.
1

.
2

.
3

e
r
i
a
n
n
o
i
t
s
e
u
Q

d
e
r
u
s
a
e
m
y
t
i
s
n
e
t
n

i

P
L
P

i

n
a
P

l
l
i

G
c
M
e
h
t

f
o
m
r
o
f

t
r
o
h
s

e
h
t

d
n
a
S
A
V
a
v

i

s
e
t
u
n
m
5
1

i

y
a
d
y
r
e
v
e

s
k
e
e
w
4

r
o
f

)
r
o
r
r
i

m
d
e
r
e
v
o
c
(

l

o
r
t
n
o
C

T
M

.
1

.
2

n
o
i
t
a
t
u
p
m
a

)
e
g
n
a
r
(

e
c
n
s

i

2
3
–
5
1
(

)
s
r
a
e
y

d
n
a
n
o
i
t
a
t
u
p
m
a

)
e
g
a
t
n
e
c
r
e
p

e
l
p
m
a
s
d
n
a

%
0
0
1
=
a
m
u
a
r
T

%
0
0
1
=
K
B

s
e
g
a
t
n
e
c
r
e
p

n
o
i
t
a
t
u
p
m
a

f
o

)
5
4
=
n
(

)
8
1
0
2
(

2
2
.
l
a
t
e

l

O

e
z
i

s

R
N

R
N

%
8
=
E
A

%
8
=
E
B

%
4
3
=
K
A

%
0
5
=
K
B

)
7
1
0
2
(

3
2
.
l
a

t

e

u
g
u
d
a
m
a
R

)
0
6
=
n
(

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

Figure 1. Risk-of-bias8 assessments for studies presented in the review of recent randomized controlled trials exploring treatment of 
phantom limb pain. Randomization: randomization sequence generation; Blinding – P & P: blinding of participants and personnel; Blinding 
– Outcome: blinding of outcome assessment; Outcome data: incomplete outcome data.

differences  in  PLP  scores  and  levels  of  depression  and  anxi-
ety  were  not  significant  at  either  follow-up  time16.  However,  
PLP  scores  at  both  follow-up  times  were  significantly  lower 
than  at  baseline  for  the  active  group  but  not  the  sham  group. 
Fifteen  days  after  treatment,  there  was  a  significantly  greater 
percentage  reduction  in  PLP  in  the  group  that  received  active 
versus  sham  rTMS;  however,  this  was  no  longer  significant 
30  days  after  treatment.  rTMS  of  the  motor  cortex  does  not  
appear  to  reduce  PLP  in  lower  extremity  amputees  to  a  greater 
extent  than  a  sham  control  condition  when  the  hand  area, 
rather  than  the  foot  area,  is  stimulated.  Future  studies  may 
prove  more  effective  by  matching  the  rTMS  stimulation  site  in  
motor cortex contralateral to the extremity amputated.

Imaginal phantom limb exercises
Cortical  reorganization  has  also  been  proposed  to  occur  as  a 
result  of  mental  imagery,  including  engaging  in  phantom  limb 
exercises  (that  is,  active  imaginal  efforts  to  move  the  phan-
tom),  under  the  assumption  that  the  neural  pathways  involved  in 
performing  actual  movements  are  activated  when  using  one’s 
imagination  to  move  the  phantom  extremity.  Initial  studies  of  
phantom limb exercises show promise in reducing PLP27,28.

In  a  2015  study,  unilateral  lower  limb  amputees  were  randomly 
assigned  to  one  of  two  groups  to  receive  progressive  muscle 

relaxation,  mental  imagery,  and  phantom  exercises  (n  =  27) 
or  residual  limb  exercises  (n  =  24)19.  The  mean  reported  time 
since  amputation  was  458  days,  and  the  majority  of  amputations 
were  due  to  diabetes  and  peripheral  vascular  disease.  The  treat-
ment  group  received  a  50-minute  combined  training  session  in 
progressive  muscle  relaxation,  mental  imagery,  and  phantom  
exercises  twice  per  week  for  4  weeks.  Phantom  exercises  involved 
imagining  moving  the  phantom  limb  and  then  attempting  to  per-
form  these  movements.  The  control  group  received  the  same 
amount  of  treatment  involving  exercising  their  residual  limb.  In 
addition,  both  groups  participated  in  a  rehabilitation  program  
involving  occupational  therapy  and  prosthesis  training,  which 
took  place  twice  per  day  for  4  weeks.  Items  from  the  Prosthesis  
Evaluation  Questionnaire  (PEQ)  and  Brief  Pain  Inventory  (BPI) 
measuring  pain  and  bodily  sensations  were  collected  at  base-
line, at the end of treatment, and 1 month after treatment. Owing 
to  participant  attrition,  only  20  participants  from  each  group 
were  included  in  the  final  analysis. At  the  end  of  treatment,  the 
two  groups  did  not  differ  significantly  on  either  the  PEQ  or  
BPI  items19.  At  the  1-month  follow-up,  the  treatment  group  had 
significantly  lower  pain  intensity  scores  on  the  BPI  worst  and 
average  pain  items  and  significantly  lower  scores  on  the  PLP 
rate,  intensity,  and  bother  items  of  the  PEQ  compared  with  the 
control  group19.  Although  preliminary  evidence  seems  promis-
ing,  the  authors  did  not  adjust  the  type  1  error  rate  for  multiple 

Page 6 of 11

comparisons.  Moreover,  the  absence  of  between-group  dif-
ferences  in  PEQ  and  BPI  outcomes  at  the  end  of  treatment  is  
puzzling  and  raises  the  possibility  that  some  factor  unrelated 
to  treatment  accounts  for  the  significant  effects  at  the  1-month 
follow-up.  Furthermore,  the  researchers  did  not  measure  the 
amputees’  self-report  of  their  ability  to  perform  the  phantom 
exercises  or  the  extent  to  which  they  engaged  in  these  move-
ments.  This  is  an  important  factor  to  measure  given  that  
self-reported motor control is a predictor of PLP severity29. More 
research is needed on the effects of combined progressive muscle 
relaxation,  mental  imagery,  and  phantom  exercises  using  larger 
sample sizes and better measures.

important 

important  since 

Mirror therapy
It  has  been  suggested  that  PLP  may  be  especially  difficult  to 
treat  because  of  the  absence  of  tactile  and  visual  feedback  from 
the  limb30.  The  role  of  the  visual  and  tactile  modality  is  espe-
cially 
information 
they  provide 
involving  exteroceptive  sensibility.  Lower  limb  amputees  fre-
quently  report  that  it  was  not  until  they  looked  under  the  bed 
sheets  and  reached  out  to  touch  the  limb  that  they  realized  it 
had  been  cut  off.  When  there  is  a  discrepancy  or  contradiction  
between  incoming  information  from  different  modalities  or 
when  a  state  of  uncertainty  exists  based  upon  somatosensory 
input  alone,  additional  information  is  sought  via  these  modali-
ties,  which  usually  determine  the  perceptual  experience.  Ampu-
tation not only results in the loss of afferent input/feedback from 
the  amputated  limb  but  also  produces  a  loss  of  visual  and  tactile 
information  related  to  the  limb.  The  central  influences  that  
normally  inhibit  pain  may  be  further  reduced  by  the  absence  of 
information  from  these  external  sources  that  might  otherwise 
confirm  or  disconfirm  the  perception  of  pain  arising  from  the  
periphery  (for  example,  a  phantom  limb  in  a  painful  position  or 
a  “crawling”  sensation  on  the  skin)30.  Thus,  some  forms  of  PLP 
may  arise,  in  part,  from  a  mechanism  involving  a  release  from  
inhibitory control (that is, disinhibition).

Self-touch  of  a  painful  area  can  gate  pain  signals  from  reach-
ing  the  brain,  therefore  minimizing  the  pain  experience31.  Look-
ing  at  one’s  own  body  has  also  been  shown  to  reduce  pain 
intensity  and  neural  responses  to  painful  stimuli  compared 
with  viewing  a  neutral  object32.  Research  on  reducing  PLP 
has  focused  on  restoring  this  lack  of  sensory  feedback.  MT  is  a  
long-standing  treatment  for  PLP33  and  is  thought  to  reduce  PLP 
by  restoring  normal  somatosensory  and  visual  inputs  to  asso-
ciated  brain  structures,  although  the  precise  mechanisms  by 
which  this  occurs  are  not  well  understood20.  A  recent  neuroim-
aging  study  of  lower  limb  amputees  with  PLP  found  enhanced 
responsiveness  to  viewing  images  of  feet  (but  not  hands)  in  the 
foot  area  of  sensorimotor  cortex  contralateral  to  the  amputated 
limb  as  well  as  in  posterior  parietal  cortex34.  Both  PLP  inten-
sity  and  the  increased  visual  responsiveness  were  abolished  
after  4  weeks  of  MT.  These  results  are  consistent  with  the  “PLP 
as  disinhibition”  hypothesis30  described  above  whereby  see-
ing  the  limb  (via  MT)  re-establishes,  in  somatosensory  and 
parietal  structures, 
inhibitory  control  processes 
which  were  lost  because  of  amputation  (that  is,  visual  deaffer-
entation).  The  restoration,  via  the  visual  modality,  of  inhibitory  
control  over  cells  in  these  and  other  brain  regions  reduces  

the  normal 

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

abnormal  brain  activity,  which  contributed  to  increased  levels  of  
PLP, and thereby reduces pain.

Five RCTs examining the efficacy of MT for PLP have been pub-
lished  over  the  past  5  years20–24.  Sample  sizes  range  from  a  total 
of  1520  to  6023. Two  studies21,22  recruited  unilateral  lower  extrem-
ity amputees only (n = 85), one study20 recruited unilateral upper 
limb  amputees  only  (n  =  15),  and  the  remaining  two  studies23,24 
recruited  both  unilateral  lower  (n  =  60)  and  unilateral  upper 
(n  =  17)  extremity  amputees.  Time  since  amputation  ranged  
from  less  than  1  month20  to  32  years22;  one  study23  did  not 
report  time  since  amputation.  MT  was  compared  with  sen-
sorimotor  exercises  with  or  without  a  covered  mirror20,21,23,  
tactile  therapy22,  or  contralateral  transcutaneous  electrical  nerve 
stimulation24,  a  treatment  that  has  been  shown  to  be  effective  for  
PLP35–37.  Parameters  of  the  MT  intervention  ranged  from  a  low 
of  a  single  20-minute  session  daily  for  4  consecutive  days24  to 
5-minute  sessions  twice  per  day  for  4  weeks22  to  a  high  of  one 
15-minute  session  daily  for  4  weeks20,21,23.  Participants  were 
instructed  to  move  both  the  intact  and  phantom  limb  synchro-
nously  during  MT  while  viewing  the  reflected  image  of  the 
intact  limb  (that  is,  the  phantom)  in  the  mirror20–23.  One  study  
did  not  specify  what  participants  were  instructed  to  do  regard-
ing phantom limb exercises24. PLP was assessed at various times, 
including  pre-treatment  baseline  and  immediately  post-treatment 
for  all  studies  and  up  to  322,  423,  or  621  months  post-treatment. 
Of  the  five  studies,  only  one  showed  significantly  lower  PLP 
intensity scores in favour of MT up to 6 months after treatment21.  
The  remaining  studies  either  did  not  report  a  between-group  test 
of PLP intensity20,23 or failed to show a significant benefit of MT 
on any measure of PLP at the end of treatment22,24. Taken together, 
the results of the most recent studies evaluating the efficacy of MT 
for PLP are not promising. Overall, MT does not appear to reduce  
PLP to a greater degree than control or other known treatments.

Virtual and augmented reality
interventions  have  recently 
Virtual  and  augmented  reality 
emerged  as  novel  approaches  to  treating  PLP.  Virtual  real-
ity  involves  completely  immersing  an  individual  in  a  virtual 
world,  whereas  augmented  reality  adds  digital  elements,  such 
as  the  missing  limb,  to  a  real  environment.  These  interventions  
represent  a  “high-tech”  alternative  to  traditional  MT38  as  they 
allow  amputees  to  move  their  intact  and  phantom  limbs  inde-
pendently  while  seeing  their  phantom  limb  integrated  into, 
and  interacting  with,  the  surrounding  setting39.  They  also  rep-
resent  a  more  engaging  form  of  treatment  which  may  increase  
adherence39.  Although  virtual  and  augmented  reality  interven-
tions  have  gained  popularity,  quality  evidence  does  not  exist  to  
support  its  efficacy40.  Existing  studies  are  typically  underpowered 
and lack comparison groups.

In  spite  of  the  excitement  and  popularity  surrounding  vir-
tual  and  augmented  reality  for  treatment  of  PLP,  only  one 
RCT  using  augmented  reality  has  been  published  in  the  past 
5  years25.  Seventy-five  unilateral  lower  limb  amputees  with  a 
median  time  since  amputation  of  about  3.5  years  were  randomly 
assigned  to  one  of  three  interventions. The  first  group  completed  
4  weeks  of  MT  followed  by  6  weeks  of  teletreatment  involv-
ing  augmented  reality  and  digital  exercise  programs.  The  second 

Page 7 of 11

group  underwent  4  weeks  of  MT  followed  by  6  weeks  of  self-
delivered  MT  (traditional  MT  group).  The  third  group  received 
4  weeks  of  sensorimotor  exercises  to  the  unamputated  limb 
and  6  weeks  of  self-delivered  exercises  (control  group).  Each  
group  received  at  least  10  30-minute  sessions  of  their  respec-
tive  intervention  across  the  initial  4  weeks.  Participants  assigned 
to  the  MT  intervention  were  instructed  to  perform  exercises 
using  their  intact  limb  in  front  of  a  mirror.  Only  once  they  per-
ceived voluntary and pain-free movements of their phantom limb 
were  they  asked  to  engage  in  phantom  exercises.  PLP  ratings 
of  intensity,  frequency,  and  duration  were  collected  at  baseline  
and 4, 10, and 24 weeks later. At the 4- and 10-week follow-ups, 
the  three  groups  did  not  differ  significantly  on  any  of  the  PLP 
measures.  At  the  6-month  follow-up,  the  duration  of  PLP  epi-
sodes  was  significantly  shorter  in  the  traditional  MT  group  in 
comparison  with  the  control  and  teletreatment  groups.  In  con-
trast, 6-month average PLP intensity and 6-month PLP frequency 
did not differ between the groups; moreover, not one of the three  
PLP  outcome  measures  showed  a  significant  between-group  dif-
ference  immediately  after  treatment  (4  weeks)  or  at  the  10-week 
follow-up.  This  raises  the  possibility  that  the  6-month  outcome 
was  due  to  factors  other  than  traditional  MT.  The  results  do 
not  favour  MT  or  augmented  reality  as  a  viable  treatment  for 
PLP.  Further  research  is  needed  to  determine  whether  virtual  
and augmented reality are effective in the treatment of PLP.

Eye movement desensitization and reprocessing
Researchers have also explored treatments that target psychologi-
cal  mechanisms  maintaining  PLP,  such  as  painful  and  traumatic 
memories.  One  such  intervention  is  EMDR  therapy.  EMDR 
is  thought  to  reduce  PLP  by  emotionally  processing  “painful  
memories”  that  are  proposed  to  maintain  PLP26.  EMDR  ther-
apy  was  compared  with  a  control  condition  in  an  RCT  of  
60  unilateral  lower  limb  amputees26.  The  reason  for  amputation  
was  trauma  (50%),  diabetes-related  complications  (45%),  or  can-
cer  (5%).  Time  since  amputation  ranged  from  2  to  38  months. 
The  control  group  received  routine  care  while  the  experimental 
group  underwent  12  one-hour  sessions  of  EMDR  administered 
by  trained  psychologists  over  1  month.  Average  PLP  ratings 
were collected at baseline, at the end of treatment, and 24 months  
later.  The  authors  did  not  report  the  results  of  a  between-group 
analysis  at  any  point  in  time.  PLP  intensity  in  the  EMDR  group 
was  significantly  lower  than  baseline  after  treatment  and  at  the 
24-month  follow-up.  In  contrast,  PLP  intensity  in  the  control 
group  remained  consistently  high  across  the  study  period.  Fur-
ther  studies  are  needed  to  determine  whether  EMDR  effectively  
reduces PLP.

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

made  it  difficult  to  treat,  and  one  specific  treatment  that  targets  
multiple  mechanisms  of  PLP  has  yet  to  evolve.  Moreover,  the  
published  literature  does  not  assess  the  putative  mechanism(s)  
causing  PLP  in  individuals  recruited  into  clinical  trials  and  so 
it  is  not  surprising  that,  on  average,  PLP  in  the  treatment  group 
does  not  differ  from  that  in  the  control  group.  This  may  explain 
why  many  of  the  treatments  available  are  ineffective.  Many 
of  the  studies  reviewed  have  small  sample  sizes  with  short  
follow-up  periods  (Table  1).  Little  has  changed  in  the  more  than 
20  years  since  the  recommendation  for  a  rational  approach  to  
assessment and management of PLP41,42. The field continues to lack 
a mechanism-based method of classifying amputees.

(CONSORT)  statement 

Recommendations for future studies
This review of RCTs conducted over the past 5 years has not dem-
onstrated consistent evidence for a given intervention. The data in 
Supplementary Tables 1 to 10 and Figure 1 show that the risk of 
bias  is  high  for  most  of  the  studies  included  in  this  review,  thus 
raising  questions  about  the  studies’  internal  validity  and  qual-
ity.  These  data  highlight  the  need  to  develop  guidelines  on  how 
to  improve  future  PLP  treatment  research.  We  suggest  that  in 
addition  to  improving  the  methodological  quality  of  studies  by 
adhering  to  the  most  recent  Consolidated  Standards  of  Reporting  
(http://www.consort-statement.
Trials 
org),  the  following  methodological  improvements  are  required: 
larger  sample  sizes,  long-term  follow-ups,  and  limiting  inclusion 
criteria  for  any  given  study  to  minimize  participant  heterogene-
ity.  We  recommend  limiting  recruitment  for  RCTs  to  upper  or 
lower  extremity  amputations,  trauma-related  or  vascular  disease- 
related  amputations,  and  short  or  long  time  since  amputation. 
Moreover,  given  the  importance  of  sex  differences  in  the  field 
of  pain43,44,  we  strongly  recommend  that  subgroup  analyses 
look  separately  at  female  and  male  amputees.  Finally,  the  use 
of  average  pain  scores  as  the  best  measure  of  treatment  effi-
cacy  has  been  criticized  on  empirical  and  theoretical  grounds45. 
Adopting  novel  data  analytical  approaches  such  as  growth  
mixture modeling for multivariate latent classes may help to iden-
tify  sub-clusters  of  patients  with  common  outcome  trajectories  
over time.

Grant information
This work was supported by funding from JK’s Canada Research 
Chair in Health Psychology. 

The  funders  had  no  role  in  study  design,  data  collection  and  
analysis, decision to publish, or preparation of the manuscript.

Summary and Conclusions
The  results  of  this  review  do  not  support  the  efficacy  of  any 
of  the  treatments  described  for  PLP,  including  TMR,  rTMS, 
imaginal  phantom  limb  exercises,  MT,  augmented  reality,  or 
EMDR  therapy.  The  multiple  mechanisms  underlying  PLP  have 

Acknowledgements
AA  is  supported  by  a  scholarship  from  the  Fonds  de  la  Recher-
che  pour  la  Santé  du  Québec.  JK  is  supported  by  a  Canadian  
Institutes  of  Health  Research  Canada  Research  Chair  in  Health  
Psychology.

Supplementary material
Supplementary Tables 1–10

Click here to access the data

Page 8 of 11

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

References

F1000 recommended

1. 

2. 

3. 

4. 

5. 

6. 

7. 

8. 

9. 

Ephraim PL, Wegener ST, MacKenzie EJ, et al.: Phantom pain, residual limb 
pain, and back pain in amputees: results of a national survey. Arch Phys Med 
Rehabil. 2005; 86(10): 1910–9.  
PubMed Abstract | Publisher Full Text 
Richardson C, Glenn S, Nurmikko T, et al.: Incidence of phantom phenomena 
including phantom limb pain 6 months after major lower limb amputation 
in patients with peripheral vascular disease. Clin J Pain. 2006; 22(4): 353–8. 
PubMed Abstract | Publisher Full Text 
Kooijman CM, Dijkstra PU, Geertzen JH, et al.: Phantom pain and phantom 
sensations in upper limb amputees: an epidemiological study. Pain. 2000; 
87(1): 33–41.  
PubMed Abstract | Publisher Full Text 
Bosmans JC, Geertzen JH, Post WJ, et al.: Factors associated with phantom 
limb pain: a 31/2-year prospective study. Clin Rehabil. 2010; 24(5): 444–53. 
PubMed Abstract | Publisher Full Text 

 Horne CE, Paul J: Pain Support for Adults with a Diabetes-Related Lower 
Limb Amputation: an Empirical Phenomenology Study. Pain Manag Nurs. 2019; 
20(3): 270–5.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
Flor H: Phantom-limb pain: characteristics, causes, and treatment. Lancet 
Neurol. 2002; 1(3): 182–9.  
PubMed Abstract | Publisher Full Text 
Subedi B, Grossberg GT: Phantom limb pain: mechanisms and treatment 
approaches. Pain Res Treat. 2011; 2011: 864605.  
PubMed Abstract | Publisher Full Text | Free Full Text 
Higgins JP, Altman DG, Gøtzsche PC, et al.: The Cochrane Collaboration’s tool 
for assessing risk of bias in randomised trials. BMJ. 2011; 343: d5928.  
PubMed Abstract | Publisher Full Text | Free Full Text 

 Dumanian GA, Potter BK, Mioton LM, et al.: Targeted Muscle Reinnervation 
Treats Neuroma and Phantom Pain in Major Limb Amputees: A Randomized 
Clinical Trial. Ann Surg. 2019; 270(2): 238–246.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

10. 

 Bowen JB, Wee CE, Kalik J, et al.: Targeted Muscle Reinnervation to 
Improve Pain, Prosthetic Tolerance, and Bioprosthetic Outcomes in the 
Amputee. Adv Wound Care (New Rochelle). 2017; 6(8): 261–7.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 

22. 

 Ol HS, Van Heng Y, Danielsson L, et al.: Mirror therapy for phantom limb 
and stump pain: a randomized controlled clinical trial in landmine amputees in 
Cambodia. Scand J Pain. 2018; 18(4): 603–10.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

23. 

 Ramadugu S, Nagabushnam SC, Katuwal N, et al.: Intervention for phantom 

limb pain: A randomized single crossover study of mirror therapy. Indian J 
Psychiatry. 2017; 59(4): 457–64.  
PubMed Abstract | Free Full Text | F1000 Recommendation 

24. 

 Tilak M, Isaac SA, Fletcher J, et al.: Mirror Therapy and Transcutaneous 

Electrical Nerve Stimulation for Management of Phantom Limb Pain in 
Amputees - A Single Blinded Randomized Controlled Trial. Physiother Res Int. 
2016; 21(2): 109–15.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

25. 

 Rothgangel A, Braun S, Winkens B, et al.: Traditional and augmented reality 

mirror therapy for patients with chronic phantom limb pain (PACT study): 
Results of a three-group, multicentre single-blind randomized controlled trial. 
Clin Rehabil. 2018; 32(12): 1591–608.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

26. 

 Rostaminejad A, Behnammoghadam M, Rostaminejad M, et al.: Efficacy of 
eye movement desensitization and reprocessing on the phantom limb pain of 
patients with amputations within a 24-month follow-up. Int J Rehabil Res. 2017; 
40(3): 209–14.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 
27.  Moseley GL: Graded motor imagery for pathologic pain: a randomized 

controlled trial. Neurology. 2006; 67(12): 2129–34.  
PubMed Abstract | Publisher Full Text 

28.  Beaumont G, Mercier C, Michon PE, et al.: Decreasing phantom limb pain 

through observation of action and imagery: a case series. Pain Med. 2011; 
12(2): 289–99.  
PubMed Abstract | Publisher Full Text 

29. 

 Kikkert S, Mezue M, Henderson Slater D, et al.: Motor correlates of phantom 

limb pain. Cortex. 2017; 95: 29–36.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 

30.  Katz J: The reality of phantom limbs. Motiv Emot. 1993; 17(3): 147–79.  

Publisher Full Text 

11.  Souza JM, Cheesborough JE, Ko JH, et al.: Targeted muscle reinnervation: a 

31.  Kammers MP, de Vignemont F, Haggard P: Cooling the thermal grill illusion 

novel approach to postamputation neuroma pain. Clin Orthop Relat Res. 2014; 
472(10): 2984–90.  
PubMed Abstract | Publisher Full Text | Free Full Text 

12. 

 Valerio IL, Dumanian GA, Jordan SW, et al.: Preemptive Treatment of 
Phantom and Residual Limb Pain with Targeted Muscle Reinnervation at the 
Time of Major Limb Amputation. J Am Coll Surg. 2019; 228(3): 217–26.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

13. 

 Bowen JB, Ruter D, Wee C, et al.: Targeted Muscle Reinnervation Technique 

in Below-Knee Amputation. Plast Reconstr Surg. 2019; 143(1): 309–12.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

14. 

 Kikkert S, Mezue M, O'Shea J, et al.: Neural basis of induced phantom limb 

pain relief. Ann Neurol. 2019; 85(1): 59–73.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 
15.  Katz J: Psychophysiological contributions to phantom limbs. Can J Psychiatry. 

1992; 37(5): 282–98.  
PubMed Abstract | Publisher Full Text 

16. 

17. 

18. 

 Malavera A, Silva FA, Fregni F, et al.: Repetitive Transcranial Magnetic 
Stimulation for Phantom Limb Pain in Land Mine Victims: A Double-Blinded, 
Randomized, Sham-Controlled Trial. J Pain. 2016; 17(8): 911–8.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 
Lefaucheur JP: Pain. In Handbook of Clinical Neurology. M.H. A. M. Lozano, Editor. 
2013; 116: 423–440.  
Publisher Full Text 

Lefaucheur JP, Drouot X, Ménard-Lefaucheur I, et al.: Motor cortex rTMS restores 
defective intracortical inhibition in chronic neuropathic pain. Neurology. 2006; 
67(9): 1568–74.  
PubMed Abstract | Publisher Full Text 

19.  Brunelli S, Morone G, Iosa M, et al.: Efficacy of progressive muscle relaxation, 

mental imagery, and phantom exercise training on phantom limb: a 
randomized controlled trial. Arch Phys Med Rehabil. 2015; 96(2): 181–7.  
PubMed Abstract | Publisher Full Text 

through self-touch. Curr Biol. 2010; 20(20): 1819–22.  
PubMed Abstract | Publisher Full Text 

32. 

 Longo MR, Betti V, Aglioti SM, et al.: Visually Induced Analgesia: Seeing the 

Body Reduces Pain. J Neurosci. 2009; 29(39): 12125–30.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

33.  Ramachandran VS, Rogers-Ramachandran D, Cobb S: Touching the phantom 

limb. Nature. 1995; 377(6549): 489–90.  
PubMed Abstract | Publisher Full Text 

34. 

 Chan AW, Bilger E, Griffin S, et al.: Visual responsiveness in sensorimotor 

cortex is increased following amputation and reduced after mirror therapy. 
Neuroimage Clin. 2019; 23: 101882.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 

35.  Carabelli RA, Kellerman WC: Phantom limb pain: Relief by application of TENS 

to contralateral extremity. Arch Phys Med Rehabil. 1985; 66(7): 466–7.  
PubMed Abstract 

36.  Giuffrida O, Simpson L, Halligan PW: Contralateral Stimulation, Using TENS, of 
Phantom Limb Pain: Two Confirmatory Cases. Pain Med. 2010; 11(1): 133–41. 
PubMed Abstract | Publisher Full Text 

37.  Katz J, France C, Melzack R: An association between phantom limb sensations 

and stump skin conductance during transcutaneous electrical nerve 
stimulation (TENS) applied to the contralateral leg: A case study. Pain. 1989; 
36(3): 367–77.  
PubMed Abstract | Publisher Full Text 

38. 

 Giummarra M: Augmented reality for treatment of phantom limb pain-are 

we there yet? Lancet. 2016; 388(10062): 2844–5.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

39. 

 Ortiz-Catalan M, Guðmundsdóttir RA, Kristoffersen MB, et al.: Phantom motor 
execution facilitated by machine learning and augmented reality as treatment 
for phantom limb pain: A single group, clinical trial in patients with chronic 
intractable phantom limb pain. Lancet. 2016; 388(10062): 2885–94.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

20. 

 Finn SB, Perry BN, Clasing JE, et al.: A Randomized, Controlled Trial of 

40. 

21. 

Mirror Therapy for Upper Extremity Phantom Limb Pain in Male Amputees. 
Front Neurol. 2017; 8: 267.  
PubMed Abstract | Publisher Full Text | Free Full Text | F1000 Recommendation 
 Anaforoğlu Külünkoğlu B, Erbahçeci F, Alkan A: A comparison of the effects 

of mirror therapy and phantom exercises on phantom limb pain. Turk J Med 
Sci. 2019; 49(1): 101–9.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

 Dunn J, Yeo E, Moghaddampour P, et al.: Virtual and augmented reality in 
the treatment of phantom limb pain: A literature review. NeuroRehabilitation. 
2017; 40(4): 595–601.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

41.  Sherman RA: Phantom limb pain. Mechanism-based management. Clin Podiatr 

Med Surg. 1994; 11(1): 85–106.  
PubMed Abstract 

42.  Sherman RA, Jones DC, Marbach JJ: Mechanism-based assessment and 

Page 9 of 11

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

management. Phantom pain. 1997; 149–166.  
Publisher Full Text 

567(7749): 448–50.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

43. 

 Rosen S, Ham B, Mogil JS: Sex differences in neuroimmunity and pain.  

J Neurosci Res. 2017; 95(1–2): 500–8.  
PubMed Abstract | Publisher Full Text | F1000 Recommendation 

44. 

 Dance A: Why the sexes don’t feel pain the same way. Nature. 2019; 

45. 

 Pagé MG, Romero Escobar EM, Ware MA, et al.: Predicting treatment 
outcomes of pain patients attending tertiary multidisciplinary pain treatment 
centers: A pain trajectory approach. Can J Pain. 2017; 1(1): 61–74.  
Publisher Full Text | F1000 Recommendation 

Page 10 of 11

F1000Research 2019, 8(F1000 Faculty Rev):1167 Last updated: 23 JUL 2019

Open Peer Review

Current Peer Review Status:

Editorial Note on the Review Process
F1000 Faculty Reviews
are peer reviewed before publication to ensure that the final, published version is comprehensive and accessible.
The reviewers who approved the final version are listed with their names and affiliations.

 are written by members of the prestigious 

. They are commissioned and

F1000 Faculty

The reviewers who approved this article are:

Version 1

1

2

Jack W Tsao
Department of Neurology, University of Tennessee Health Science Center, Memphis, USA
Competing Interests:
Tamar R Makin
Institute of Cognitive Neuroscience, University College London, London, UK
Competing Interests:

 No competing interests were disclosed.

 No competing interests were disclosed.

The benefits of publishing with F1000Research:

Your article is published within days, with no editorial bias

You can publish traditional articles, null/negative results, case reports, data notes and more

The peer review process is transparent and collaborative

Your article is indexed in PubMed after passing peer review

Dedicated customer support at every stage

For pre-submission enquiries, contact 

research@f1000.com

Page 11 of 11
